Pertussis (Whooping Cough) (Infectious Disease) - Drugs in Development, 2021

Publisher Name :
Date: 30-Nov-2021
No. of pages: 143
Inquire Before Buying

Pertussis (Whooping Cough) (Infectious Disease) - Drugs in Development, 2021

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pertussis - Drugs In Development, 2021, provides an overview of the Pertussis (Infectious Disease) pipeline landscape.

Pertussis, also known as whooping cough, is a highly contagious respiratory disease. It is caused by the bacterium Bordetella pertussis. Symptoms include runny nose, nasal congestion, sneezing, red, watery eyes and dry cough. Treatment includes antibiotics.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Pertussis - Drugs In Development, 2021, provides comprehensive information on the therapeutics under development for Pertussis (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Pertussis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Pertussis (Whooping Cough) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 7, 6, 12, 1, 14, 3 and 1 respectively. Similarly, the Universities portfolio in Phase II, Preclinical, Discovery and Unknown stages comprises 1, 2, 2 and 1 molecules, respectively.

Pertussis (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Pertussis (Infectious Disease).

- The pipeline guide reviews pipeline therapeutics for Pertussis (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Pertussis (Infectious Disease) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Pertussis (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Pertussis (Infectious Disease)

Reasons to Buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Pertussis (Infectious Disease).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Pertussis (Infectious Disease) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Pertussis (Whooping Cough) (Infectious Disease) - Drugs in Development, 2021

Table of Contents
Introduction
Global Markets Direct Report Coverage
Pertussis - Overview
Pertussis - Therapeutics Development
Pertussis - Therapeutics Assessment
Pertussis - Companies Involved in Therapeutics Development
Pertussis - Drug Profiles
Pertussis - Dormant Projects
Pertussis - Discontinued Products
Pertussis - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Pertussis (Whooping Cough), 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Companies, 2021 (Contd..1)
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Companies, 2021 (Contd..1)
Products under Development by Companies, 2021 (Contd..2)
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Pertussis (Whooping Cough) - Pipeline by Adjuvance Technologies Inc, 2021
Pertussis (Whooping Cough) - Pipeline by AIM Vaccine Co Ltd, 2021
Pertussis (Whooping Cough) - Pipeline by Beijing Minhai Biotechnology Co Ltd, 2021
Pertussis (Whooping Cough) - Pipeline by Beijing Tiantan Biological Products Co Ltd, 2021
Pertussis (Whooping Cough) - Pipeline by Bharat Biotech Ltd, 2021
Pertussis (Whooping Cough) - Pipeline by Biken Co Ltd, 2021
Pertussis (Whooping Cough) - Pipeline by Biological E Ltd, 2021
Pertussis (Whooping Cough) - Pipeline by BioNet-Asia Co Ltd, 2021
Pertussis (Whooping Cough) - Pipeline by Boryung Pharmaceutical Co Ltd, 2021
Pertussis (Whooping Cough) - Pipeline by Cadila Healthcare Ltd, 2021
Pertussis (Whooping Cough) - Pipeline by CanSino Biologics Inc, 2021
Pertussis (Whooping Cough) - Pipeline by Changchun Bcht Biotechnology Co Ltd, 2021
Pertussis (Whooping Cough) - Pipeline by Chongqing Zhifei Biological Products Co Ltd, 2021
Pertussis (Whooping Cough) - Pipeline by DBV Technologies SA, 2021
Pertussis (Whooping Cough) - Pipeline by Dynavax Technologies Corp, 2021
Pertussis (Whooping Cough) - Pipeline by Faron Pharmaceuticals Oy, 2021
Pertussis (Whooping Cough) - Pipeline by Gamaleya Federal Research Center of Epidemiology and Microbiology, 2021
Pertussis (Whooping Cough) - Pipeline by GC Pharma, 2021
Pertussis (Whooping Cough) - Pipeline by GlaxoSmithKline Plc, 2021
Pertussis (Whooping Cough) - Pipeline by ILiAD Biotechnologies LLC, 2021
Pertussis (Whooping Cough) - Pipeline by KM Biologics Co Ltd, 2021
Pertussis (Whooping Cough) - Pipeline by LG Chem Ltd, 2021
Pertussis (Whooping Cough) - Pipeline by Novo Medi Sciences Pvt Ltd, 2021
Pertussis (Whooping Cough) - Pipeline by Olymvax Biopharmaceuticals Inc, 2021
Pertussis (Whooping Cough) - Pipeline by Panacea Biotec Ltd, 2021
Pertussis (Whooping Cough) - Pipeline by Sanofi, 2021
Pertussis (Whooping Cough) - Pipeline by Serum Institute of India Pvt Ltd, 2021
Pertussis (Whooping Cough) - Pipeline by Shantha Biotechnics Pvt Ltd, 2021
Pertussis (Whooping Cough) - Pipeline by Suzhou Weichao Biotechnology Co Ltd, 2021
Pertussis (Whooping Cough) - Pipeline by Synthetic Biologics Inc, 2021
Pertussis (Whooping Cough) - Pipeline by VaxForm LLC, 2021
Pertussis (Whooping Cough) - Pipeline by Yisheng Biopharma Co Ltd, 2021
Pertussis (Whooping Cough) - Dormant Projects, 2021
Pertussis (Whooping Cough) - Dormant Projects, 2021 (Contd..1)
Pertussis (Whooping Cough) - Discontinued Products, 2021

List of Figures
Number of Products under Development for Pertussis (Whooping Cough), 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Targets, 2021
Number of Products by Stage and Targets, 2021
Number of Products by Mechanism of Actions, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Top 10 Molecule Types, 2021
Number of Products by Stage and Top 10 Molecule Types, 2021
  • 2022-2030 Report on Global Cephalosporin Market by Player, Region, Type, Application and Sales Channel
    Published: 17-May-2022        Price: US 2500 Onwards        Pages: 138
    This report studies the Cephalosporin market, covering market size for segment by type (First Generation, Second Generation, etc.), by application (Oral, Injection, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Union Chempharma, NCPC, Qilu Antibiotics, Lupin Pharmaceuticals, Hospira, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for C......
  • (Post-pandemic Era) - Global Cefprozil Market Segment Research Report 2022
    Published: 13-May-2022        Price: US 2950 Onwards        Pages: 113
    Summary The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery. 2022 is a year of continuous recovery. Global supply chain disturba......
  • (Post-pandemic Era) - Global Clotrimazole Market Segment Research Report 2022
    Published: 13-May-2022        Price: US 2950 Onwards        Pages: 112
    Summary The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery. 2022 is a year of continuous recovery. Global supply chain disturba......
  • Global Moxifloxacin Hydrochloride Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
    Published: 08-May-2022        Price: US 3480 Onwards        Pages: 105
    The Moxifloxacin Hydrochloride market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our (Gl......
  • Schistosomiasis mansoni Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
    Published: 02-May-2022        Price: US 2000 Onwards        Pages: 36
    Schistosomiasis mansoni Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players Summary Schistosomiasis mansoni Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Schistosomiasis mansoni Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Schistosomiasis mansoni Infections, complete with an......
  • Cefazolin Sodium Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type
    Published: 02-May-2022        Price: US 3500 Onwards        Pages: 89
    This report describes the global market size of Cefazolin Sodium from 2017 to 2021 and its CAGR from 2017 to 2021, and also forecasts its market size to the end of 2027 and its CAGR from 2022 to 2027. For geography segment, regional supply, demand, major players, price is presented from 2017 to 2027. This report cover following regions: North America South America Asia & Pacific Europe MEA The key countries for each regions are also include......
  • Zygomycosis (Mucormycosis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
    Published: 02-May-2022        Price: US 2000 Onwards        Pages: 38
    Zygomycosis (Mucormycosis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players Summary Zygomycosis (Mucormycosis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Zygomycosis (Mucormycosis) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Zygomycosis (Mucormycosis), complete with analysis by Stage of Development, ......
  • Varicella Zoster (HHV-3) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
    Published: 02-May-2022        Price: US 2000 Onwards        Pages: 74
    Varicella Zoster (HHV-3) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players Summary Varicella Zoster (HHV-3) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Varicella Zoster (HHV-3) Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Varicella Zoster (HHV-3) Infections, complete wit......
  • Human Metapneumovirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
    Published: 02-May-2022        Price: US 2000 Onwards        Pages: 46
    Human Metapneumovirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players Summary Human Metapneumovirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Human Metapneumovirus Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Human Metapneumovirus Infections, complete with analysis b......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs